Global Gastroesophageal Reflux Drugs Market Growth 2020-2025
According to this study, over the next five years the Gastroesophageal Reflux Drugs market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Gastroesophageal Reflux Drugs business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Gastroesophageal Reflux Drugs market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Gastroesophageal Reflux Drugs, covering the supply chain analysis, impact assessment to the Gastroesophageal Reflux Drugs market size growth rate in several scenarios, and the measures to be undertaken by Gastroesophageal Reflux Drugs companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Esomeprazole
Lansoprazole
Omeprazole
Rbeprazole
Dexlansoprazole
Others
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Hospitals
Ambulatory surgical centers
Specialty clinics
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Bayer
Luoxin
Cadila Pharmaceuticals
Jiangsu Aosaikang
Eisai
AstraZeneca
Takeda
Pfizer
NCPC
Altana Pharma
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Gastroesophageal Reflux Drugs consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Gastroesophageal Reflux Drugs market by identifying its various subsegments.
Focuses on the key global Gastroesophageal Reflux Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Gastroesophageal Reflux Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Gastroesophageal Reflux Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Gastroesophageal Reflux Drugs Consumption 2015-2025
2.1.2 Gastroesophageal Reflux Drugs Consumption CAGR by Region
2.2 Gastroesophageal Reflux Drugs Segment by Type
2.2.1 Esomeprazole
2.2.2 Lansoprazole
2.2.3 Omeprazole
2.2.4 Rbeprazole
2.2.5 Dexlansoprazole
2.2.6 Others
2.3 Gastroesophageal Reflux Drugs Consumption by Type
2.3.1 Global Gastroesophageal Reflux Drugs Consumption Market Share by Type (2015-2020)
2.3.2 Global Gastroesophageal Reflux Drugs Revenue and Market Share by Type (2015-2020)
2.3.3 Global Gastroesophageal Reflux Drugs Sale Price by Type (2015-2020)
2.4 Gastroesophageal Reflux Drugs Segment by Application
2.4.1 Hospitals
2.4.2 Ambulatory surgical centers
2.4.3 Specialty clinics
2.4.4 Others
2.5 Gastroesophageal Reflux Drugs Consumption by Application
2.5.1 Global Gastroesophageal Reflux Drugs Consumption Market Share by Type (2015-2020)
2.5.2 Global Gastroesophageal Reflux Drugs Value and Market Share by Type (2015-2020)
2.5.3 Global Gastroesophageal Reflux Drugs Sale Price by Type (2015-2020)
3 Global Gastroesophageal Reflux Drugs by Company
3.1 Global Gastroesophageal Reflux Drugs Sales Market Share by Company
3.1.1 Global Gastroesophageal Reflux Drugs Sales by Company (2018-2020)
3.1.2 Global Gastroesophageal Reflux Drugs Sales Market Share by Company (2018-2020)
3.2 Global Gastroesophageal Reflux Drugs Revenue Market Share by Company
3.2.1 Global Gastroesophageal Reflux Drugs Revenue by Company (2018-2020)
3.2.2 Global Gastroesophageal Reflux Drugs Revenue Market Share by Company (2018-2020)
3.3 Global Gastroesophageal Reflux Drugs Sale Price by Company
3.4 Global Gastroesophageal Reflux Drugs Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Gastroesophageal Reflux Drugs Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Gastroesophageal Reflux Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Gastroesophageal Reflux Drugs by Regions
4.1 Gastroesophageal Reflux Drugs by Regions
4.2 Americas Gastroesophageal Reflux Drugs Consumption Growth
4.3 APAC Gastroesophageal Reflux Drugs Consumption Growth
4.4 Europe Gastroesophageal Reflux Drugs Consumption Growth
4.5 Middle East & Africa Gastroesophageal Reflux Drugs Consumption Growth
5 Americas
5.1 Americas Gastroesophageal Reflux Drugs Consumption by Countries
5.1.1 Americas Gastroesophageal Reflux Drugs Consumption by Countries (2015-2020)
5.1.2 Americas Gastroesophageal Reflux Drugs Value by Countries (2015-2020)
5.2 Americas Gastroesophageal Reflux Drugs Consumption by Type
5.3 Americas Gastroesophageal Reflux Drugs Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Gastroesophageal Reflux Drugs Consumption by Regions
6.1.1 APAC Gastroesophageal Reflux Drugs Consumption by Regions (2015-2020)
6.1.2 APAC Gastroesophageal Reflux Drugs Value by Regions (2015-2020)
6.2 APAC Gastroesophageal Reflux Drugs Consumption by Type
6.3 APAC Gastroesophageal Reflux Drugs Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Gastroesophageal Reflux Drugs by Countries
7.1.1 Europe Gastroesophageal Reflux Drugs Consumption by Countries (2015-2020)
7.1.2 Europe Gastroesophageal Reflux Drugs Value by Countries (2015-2020)
7.2 Europe Gastroesophageal Reflux Drugs Consumption by Type
7.3 Europe Gastroesophageal Reflux Drugs Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Gastroesophageal Reflux Drugs by Countries
8.1.1 Middle East & Africa Gastroesophageal Reflux Drugs Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Gastroesophageal Reflux Drugs Value by Countries (2015-2020)
8.2 Middle East & Africa Gastroesophageal Reflux Drugs Consumption by Type
8.3 Middle East & Africa Gastroesophageal Reflux Drugs Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Gastroesophageal Reflux Drugs Distributors
10.3 Gastroesophageal Reflux Drugs Customer
11 Global Gastroesophageal Reflux Drugs Market Forecast
11.1 Global Gastroesophageal Reflux Drugs Consumption Forecast (2021-2025)
11.2 Global Gastroesophageal Reflux Drugs Forecast by Regions
11.2.1 Global Gastroesophageal Reflux Drugs Forecast by Regions (2021-2025)
11.2.2 Global Gastroesophageal Reflux Drugs Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Gastroesophageal Reflux Drugs Forecast by Type
11.8 Global Gastroesophageal Reflux Drugs Forecast by Application
12 Key Players Analysis
12.1 Bayer
12.1.1 Company Information
12.1.2 Gastroesophageal Reflux Drugs Product Offered
12.1.3 Bayer Gastroesophageal Reflux Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Bayer Latest Developments
12.2 Luoxin
12.2.1 Company Information
12.2.2 Gastroesophageal Reflux Drugs Product Offered
12.2.3 Luoxin Gastroesophageal Reflux Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Luoxin Latest Developments
12.3 Cadila Pharmaceuticals
12.3.1 Company Information
12.3.2 Gastroesophageal Reflux Drugs Product Offered
12.3.3 Cadila Pharmaceuticals Gastroesophageal Reflux Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Cadila Pharmaceuticals Latest Developments
12.4 Jiangsu Aosaikang
12.4.1 Company Information
12.4.2 Gastroesophageal Reflux Drugs Product Offered
12.4.3 Jiangsu Aosaikang Gastroesophageal Reflux Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Jiangsu Aosaikang Latest Developments
12.5 Eisai
12.5.1 Company Information
12.5.2 Gastroesophageal Reflux Drugs Product Offered
12.5.3 Eisai Gastroesophageal Reflux Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Eisai Latest Developments
12.6 AstraZeneca
12.6.1 Company Information
12.6.2 Gastroesophageal Reflux Drugs Product Offered
12.6.3 AstraZeneca Gastroesophageal Reflux Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 AstraZeneca Latest Developments
12.7 Takeda
12.7.1 Company Information
12.7.2 Gastroesophageal Reflux Drugs Product Offered
12.7.3 Takeda Gastroesophageal Reflux Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Takeda Latest Developments
12.8 Pfizer
12.8.1 Company Information
12.8.2 Gastroesophageal Reflux Drugs Product Offered
12.8.3 Pfizer Gastroesophageal Reflux Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Pfizer Latest Developments
12.9 NCPC
12.9.1 Company Information
12.9.2 Gastroesophageal Reflux Drugs Product Offered
12.9.3 NCPC Gastroesophageal Reflux Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 NCPC Latest Developments
12.10 Altana Pharma
12.10.1 Company Information
12.10.2 Gastroesophageal Reflux Drugs Product Offered
12.10.3 Altana Pharma Gastroesophageal Reflux Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Altana Pharma Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Gastroesophageal Reflux Drugs Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Esomeprazole
Table 5. Major Players of Lansoprazole
Table 6. Major Players of Omeprazole
Table 7. Major Players of Rbeprazole
Table 8. Major Players of Dexlansoprazole
Table 9. Major Players of Others
Table 10. Global Consumption Sales by Type (2015-2020)
Table 11. Global Gastroesophageal Reflux Drugs Consumption Market Share by Type (2015-2020)
Table 12. Global Gastroesophageal Reflux Drugs Revenue by Type (2015-2020) ($ million)
Table 13. Global Gastroesophageal Reflux Drugs Value Market Share by Type (2015-2020) ($ Millions)
Table 14. Global Gastroesophageal Reflux Drugs Sale Price by Type (2015-2020)
Table 15. Global Consumption Sales by Application (2015-2020)
Table 16. Global Gastroesophageal Reflux Drugs Consumption Market Share by Application (2015-2020)
Table 17. Global Gastroesophageal Reflux Drugs Value by Application (2015-2020)
Table 18. Global Gastroesophageal Reflux Drugs Value Market Share by Application (2015-2020)
Table 19. Global Gastroesophageal Reflux Drugs Sale Price by Application (2015-2020)
Table 20. Global Gastroesophageal Reflux Drugs Sales by Company (2017-2019) (K Units)
Table 21. Global Gastroesophageal Reflux Drugs Sales Market Share by Company (2017-2019)
Table 22. Global Gastroesophageal Reflux Drugs Revenue by Company (2017-2019) ($ Millions)
Table 23. Global Gastroesophageal Reflux Drugs Revenue Market Share by Company (2017-2019)
Table 24. Global Gastroesophageal Reflux Drugs Sale Price by Company (2017-2019)
Table 25. Global Gastroesophageal Reflux Drugs Manufacturing Base Distribution and Sales Area by Manufacturers
Table 26. Players Gastroesophageal Reflux Drugs Products Offered
Table 27. Gastroesophageal Reflux Drugs Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 28. Global Gastroesophageal Reflux Drugs Consumption by Regions 2015-2020 (K Units)
Table 29. Global Gastroesophageal Reflux Drugs Consumption Market Share by Regions 2015-2020
Table 30. Global Gastroesophageal Reflux Drugs Value by Regions 2015-2020 ($ Millions)
Table 31. Global Gastroesophageal Reflux Drugs Value Market Share by Regions 2015-2020
Table 32. Americas Gastroesophageal Reflux Drugs Consumption by Countries (2015-2020) (K Units)
Table 33. Americas Gastroesophageal Reflux Drugs Consumption Market Share by Countries (2015-2020)
Table 34. Americas Gastroesophageal Reflux Drugs Value by Countries (2015-2020) ($ Millions)
Table 35. Americas Gastroesophageal Reflux Drugs Value Market Share by Countries (2015-2020)
Table 36. Americas Gastroesophageal Reflux Drugs Consumption by Type (2015-2020) (K Units)
Table 37. Americas Gastroesophageal Reflux Drugs Consumption Market Share by Type (2015-2020)
Table 38. Americas Gastroesophageal Reflux Drugs Consumption by Application (2015-2020) (K Units)
Table 39. Americas Gastroesophageal Reflux Drugs Consumption Market Share by Application (2015-2020)
Table 40. APAC Gastroesophageal Reflux Drugs Consumption by Countries (2015-2020) (K Units)
Table 41. APAC Gastroesophageal Reflux Drugs Consumption Market Share by Countries (2015-2020)
Table 42. APAC Gastroesophageal Reflux Drugs Value by Regions (2015-2020) ($ Millions)
Table 43. APAC Gastroesophageal Reflux Drugs Value Market Share by Regions (2015-2020)
Table 44. APAC Gastroesophageal Reflux Drugs Consumption by Type (2015-2020) (K Units)
Table 45. APAC Gastroesophageal Reflux Drugs Consumption Market Share by Type (2015-2020)
Table 46. APAC Gastroesophageal Reflux Drugs Consumption by Application (2015-2020) (K Units)
Table 47. APAC Gastroesophageal Reflux Drugs Consumption Market Share by Application (2015-2020)
Table 48. Europe Gastroesophageal Reflux Drugs Consumption by Countries (2015-2020) (K Units)
Table 49. Europe Gastroesophageal Reflux Drugs Consumption Market Share by Countries (2015-2020)
Table 50. Europe Gastroesophageal Reflux Drugs Value by Countries (2015-2020) ($ Millions)
Table 51. Europe Gastroesophageal Reflux Drugs Value Market Share by Countries (2015-2020)
Table 52. Europe Gastroesophageal Reflux Drugs Consumption by Type (2015-2020) (K Units)
Table 53. Europe Gastroesophageal Reflux Drugs Consumption Market Share by Type (2015-2020)
Table 54. Europe Gastroesophageal Reflux Drugs Consumption by Application (2015-2020) (K Units)
Table 55. Europe Gastroesophageal Reflux Drugs Consumption Market Share by Application (2015-2020)
Table 56. Middle East & Africa Gastroesophageal Reflux Drugs Consumption by Countries (2015-2020) (K Units)
Table 57. Middle East & Africa Gastroesophageal Reflux Drugs Consumption Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Gastroesophageal Reflux Drugs Value by Countries (2015-2020) ($ Millions)
Table 59. Middle East & Africa Gastroesophageal Reflux Drugs Value Market Share by Countries (2015-2020)
Table 60. Middle East & Africa Gastroesophageal Reflux Drugs Consumption by Type (2015-2020) (K Units)
Table 61. Middle East & Africa Gastroesophageal Reflux Drugs Consumption Market Share by Type (2015-2020)
Table 62. Middle East & Africa Gastroesophageal Reflux Drugs Consumption by Application (2015-2020) (K Units)
Table 63. Middle East & Africa Gastroesophageal Reflux Drugs Consumption Market Share by Application (2015-2020)
Table 64. Gastroesophageal Reflux Drugs Distributors List
Table 65. Gastroesophageal Reflux Drugs Customer List
Table 66. Global Gastroesophageal Reflux Drugs Consumption Forecast by Countries (2021-2025) (K Units)
Table 67. Global Gastroesophageal Reflux Drugs Consumption Market Forecast by Regions
Table 68. Global Gastroesophageal Reflux Drugs Value Forecast by Countries (2021-2025) ($ Millions)
Table 69. Global Gastroesophageal Reflux Drugs Value Market Share Forecast by Regions
Table 70. Global Gastroesophageal Reflux Drugs Consumption Forecast by Type (2021-2025) (K Units)
Table 71. Global Gastroesophageal Reflux Drugs Consumption Market Share Forecast by Type (2021-2025)
Table 72. Global Gastroesophageal Reflux Drugs Value Forecast by Type (2021-2025) ($ Millions)
Table 73. Global Gastroesophageal Reflux Drugs Value Market Share Forecast by Type (2021-2025)
Table 74. Global Gastroesophageal Reflux Drugs Consumption Forecast by Application (2021-2025) (K Units)
Table 75. Global Gastroesophageal Reflux Drugs Consumption Market Share Forecast by Application (2021-2025)
Table 76. Global Gastroesophageal Reflux Drugs Value Forecast by Application (2021-2025) ($ Millions)
Table 77. Global Gastroesophageal Reflux Drugs Value Market Share Forecast by Application (2021-2025)
Table 78. Bayer Product Offered
Table 79. Bayer Gastroesophageal Reflux Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 80. Bayer Main Business
Table 81. Bayer Latest Developments
Table 82. Bayer Basic Information, Company Total Revenue (in $ million), Gastroesophageal Reflux Drugs Manufacturing Base, Sales Area and Its Competitors
Table 83. Luoxin Product Offered
Table 84. Luoxin Gastroesophageal Reflux Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 85. Luoxin Main Business
Table 86. Luoxin Latest Developments
Table 87. Luoxin Basic Information, Company Total Revenue (in $ million), Gastroesophageal Reflux Drugs Manufacturing Base, Sales Area and Its Competitors
Table 88. Cadila Pharmaceuticals Product Offered
Table 89. Cadila Pharmaceuticals Gastroesophageal Reflux Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 90. Cadila Pharmaceuticals Main Business
Table 91. Cadila Pharmaceuticals Latest Developments
Table 92. Cadila Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Gastroesophageal Reflux Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. Jiangsu Aosaikang Product Offered
Table 94. Jiangsu Aosaikang Gastroesophageal Reflux Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 95. Jiangsu Aosaikang Main Business
Table 96. Jiangsu Aosaikang Latest Developments
Table 97. Jiangsu Aosaikang Basic Information, Company Total Revenue (in $ million), Gastroesophageal Reflux Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. Eisai Product Offered
Table 99. Eisai Gastroesophageal Reflux Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 100. Eisai Main Business
Table 101. Eisai Latest Developments
Table 102. Eisai Basic Information, Company Total Revenue (in $ million), Gastroesophageal Reflux Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. AstraZeneca Product Offered
Table 104. AstraZeneca Gastroesophageal Reflux Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 105. AstraZeneca Main Business
Table 106. AstraZeneca Latest Developments
Table 107. AstraZeneca Basic Information, Company Total Revenue (in $ million), Gastroesophageal Reflux Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. Takeda Product Offered
Table 109. Takeda Basic Information, Company Total Revenue (in $ million), Gastroesophageal Reflux Drugs Manufacturing Base, Sales Area and Its Competitors
Table 110. Takeda Main Business
Table 111. Takeda Latest Developments
Table 112. Takeda Gastroesophageal Reflux Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 113. Pfizer Product Offered
Table 114. Pfizer Gastroesophageal Reflux Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 115. Pfizer Main Business
Table 116. Pfizer Latest Developments
Table 117. Pfizer Basic Information, Company Total Revenue (in $ million), Gastroesophageal Reflux Drugs Manufacturing Base, Sales Area and Its Competitors
Table 118. NCPC Product Offered
Table 119. NCPC Gastroesophageal Reflux Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 120. NCPC Main Business
Table 121. NCPC Latest Developments
Table 122. NCPC Basic Information, Company Total Revenue (in $ million), Gastroesophageal Reflux Drugs Manufacturing Base, Sales Area and Its Competitors
Table 123. Altana Pharma Product Offered
Table 124. Altana Pharma Gastroesophageal Reflux Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 125. Altana Pharma Main Business
Table 126. Altana Pharma Latest Developments
Table 127. Altana Pharma Basic Information, Company Total Revenue (in $ million), Gastroesophageal Reflux Drugs Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Gastroesophageal Reflux Drugs
Figure 2. Gastroesophageal Reflux Drugs Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Gastroesophageal Reflux Drugs Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Gastroesophageal Reflux Drugs Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Esomeprazole
Figure 7. Product Picture of Lansoprazole
Figure 8. Product Picture of Omeprazole
Figure 9. Product Picture of Rbeprazole
Figure 10. Product Picture of Dexlansoprazole
Figure 11. Product Picture of Others
Figure 12. Global Gastroesophageal Reflux Drugs Consumption Market Share by Type (2015-2020)
Figure 13. Global Gastroesophageal Reflux Drugs Value Market Share by Type (2015-2020)
Figure 14. Gastroesophageal Reflux Drugs Consumed in Hospitals
Figure 15. Global Gastroesophageal Reflux Drugs Market: Hospitals (2015-2020) (K Units)
Figure 16. Global Gastroesophageal Reflux Drugs Market: Hospitals (2015-2020) ($ Millions)
Figure 17. Gastroesophageal Reflux Drugs Consumed in Ambulatory surgical centers
Figure 18. Global Gastroesophageal Reflux Drugs Market: Ambulatory surgical centers (2015-2020) (K Units)
Figure 19. Global Gastroesophageal Reflux Drugs Market: Ambulatory surgical centers (2015-2020) ($ Millions)
Figure 20. Gastroesophageal Reflux Drugs Consumed in Specialty clinics
Figure 21. Global Gastroesophageal Reflux Drugs Market: Specialty clinics (2015-2020) (K Units)
Figure 22. Global Gastroesophageal Reflux Drugs Market: Specialty clinics (2015-2020) ($ Millions)
Figure 23. Gastroesophageal Reflux Drugs Consumed in Others
Figure 24. Global Gastroesophageal Reflux Drugs Market: Others (2015-2020) (K Units)
Figure 25. Global Gastroesophageal Reflux Drugs Market: Others (2015-2020) ($ Millions)
Figure 26. Global Gastroesophageal Reflux Drugs Consumption Market Share by Application (2015-2020)
Figure 27. Global Gastroesophageal Reflux Drugs Value Market Share by Application (2015-2020)
Figure 28. Global Gastroesophageal Reflux Drugs Sales Market Share by Company in 2017
Figure 29. Global Gastroesophageal Reflux Drugs Sales Market Share by Company in 2019
Figure 30. Global Gastroesophageal Reflux Drugs Revenue Market Share by Company in 2017
Figure 31. Global Gastroesophageal Reflux Drugs Revenue Market Share by Company in 2019
Figure 32. Global Gastroesophageal Reflux Drugs Sale Price by Company in 2019
Figure 33. Global Gastroesophageal Reflux Drugs Consumption Market Share by Regions 2015-2020
Figure 34. Global Gastroesophageal Reflux Drugs Value Market Share by Regions 2015-2020
Figure 35. Americas Gastroesophageal Reflux Drugs Consumption 2015-2020 (K Units)
Figure 36. Americas Gastroesophageal Reflux Drugs Value 2015-2020 ($ Millions)
Figure 37. APAC Gastroesophageal Reflux Drugs Consumption 2015-2020 (K Units)
Figure 38. APAC Gastroesophageal Reflux Drugs Value 2015-2020 ($ Millions)
Figure 39. Europe Gastroesophageal Reflux Drugs Consumption 2015-2020 (K Units)
Figure 40. Europe Gastroesophageal Reflux Drugs Value 2015-2020 ($ Millions)
Figure 41. Middle East & Africa Gastroesophageal Reflux Drugs Consumption 2015-2020 (K Units)
Figure 42. Middle East & Africa Gastroesophageal Reflux Drugs Value 2015-2020 ($ Millions)
Figure 43. Americas Gastroesophageal Reflux Drugs Consumption Market Share by Countries in 2019
Figure 44. Americas Gastroesophageal Reflux Drugs Value Market Share by Countries in 2019
Figure 45. Americas Gastroesophageal Reflux Drugs Consumption Market Share by Type in 2019
Figure 46. Americas Gastroesophageal Reflux Drugs Consumption Market Share by Application in 2019
Figure 47. United States Gastroesophageal Reflux Drugs Consumption Growth 2015-2020 (K Units)
Figure 48. United States Gastroesophageal Reflux Drugs Value Growth 2015-2020 ($ Millions)
Figure 49. Canada Gastroesophageal Reflux Drugs Consumption Growth 2015-2020 (K Units)
Figure 50. Canada Gastroesophageal Reflux Drugs Value Growth 2015-2020 ($ Millions)
Figure 51. Mexico Gastroesophageal Reflux Drugs Consumption Growth 2015-2020 (K Units)
Figure 52. Mexico Gastroesophageal Reflux Drugs Value Growth 2015-2020 ($ Millions)
Figure 53. APAC Gastroesophageal Reflux Drugs Consumption Market Share by Countries in 2019
Figure 54. APAC Gastroesophageal Reflux Drugs Value Market Share by Regions in 2019
Figure 55. APAC Gastroesophageal Reflux Drugs Consumption Market Share by Type in 2019
Figure 56. APAC Gastroesophageal Reflux Drugs Consumption Market Share by Application in 2019
Figure 57. China Gastroesophageal Reflux Drugs Consumption Growth 2015-2020 (K Units)
Figure 58. China Gastroesophageal Reflux Drugs Value Growth 2015-2020 ($ Millions)
Figure 59. Japan Gastroesophageal Reflux Drugs Consumption Growth 2015-2020 (K Units)
Figure 60. Japan Gastroesophageal Reflux Drugs Value Growth 2015-2020 ($ Millions)
Figure 61. Korea Gastroesophageal Reflux Drugs Consumption Growth 2015-2020 (K Units)
Figure 62. Korea Gastroesophageal Reflux Drugs Value Growth 2015-2020 ($ Millions)
Figure 63. Southeast Asia Gastroesophageal Reflux Drugs Consumption Growth 2015-2020 (K Units)
Figure 64. Southeast Asia Gastroesophageal Reflux Drugs Value Growth 2015-2020 ($ Millions)
Figure 65. India Gastroesophageal Reflux Drugs Consumption Growth 2015-2020 (K Units)
Figure 66. India Gastroesophageal Reflux Drugs Value Growth 2015-2020 ($ Millions)
Figure 67. Australia Gastroesophageal Reflux Drugs Consumption Growth 2015-2020 (K Units)
Figure 68. Australia Gastroesophageal Reflux Drugs Value Growth 2015-2020 ($ Millions)
Figure 69. Europe Gastroesophageal Reflux Drugs Consumption Market Share by Countries in 2019
Figure 70. Europe Gastroesophageal Reflux Drugs Value Market Share by Countries in 2019
Figure 71. Europe Gastroesophageal Reflux Drugs Consumption Market Share by Type in 2019
Figure 72. Europe Gastroesophageal Reflux Drugs Consumption Market Share by Application in 2019
Figure 73. Germany Gastroesophageal Reflux Drugs Consumption Growth 2015-2020 (K Units)
Figure 74. Germany Gastroesophageal Reflux Drugs Value Growth 2015-2020 ($ Millions)
Figure 75. France Gastroesophageal Reflux Drugs Consumption Growth 2015-2020 (K Units)
Figure 76. France Gastroesophageal Reflux Drugs Value Growth 2015-2020 ($ Millions)
Figure 77. UK Gastroesophageal Reflux Drugs Consumption Growth 2015-2020 (K Units)
Figure 78. UK Gastroesophageal Reflux Drugs Value Growth 2015-2020 ($ Millions)
Figure 79. Italy Gastroesophageal Reflux Drugs Consumption Growth 2015-2020 (K Units)
Figure 80. Italy Gastroesophageal Reflux Drugs Value Growth 2015-2020 ($ Millions)
Figure 81. Russia Gastroesophageal Reflux Drugs Consumption Growth 2015-2020 (K Units)
Figure 82. Russia Gastroesophageal Reflux Drugs Value Growth 2015-2020 ($ Millions)
Figure 83. Middle East & Africa Gastroesophageal Reflux Drugs Consumption Market Share by Countries in 2019
Figure 84. Middle East & Africa Gastroesophageal Reflux Drugs Value Market Share by Countries in 2019
Figure 85. Middle East & Africa Gastroesophageal Reflux Drugs Consumption Market Share by Type in 2019
Figure 86. Middle East & Africa Gastroesophageal Reflux Drugs Consumption Market Share by Application in 2019
Figure 87. Egypt Gastroesophageal Reflux Drugs Consumption Growth 2015-2020 (K Units)
Figure 88. Egypt Gastroesophageal Reflux Drugs Value Growth 2015-2020 ($ Millions)
Figure 89. South Africa Gastroesophageal Reflux Drugs Consumption Growth 2015-2020 (K Units)
Figure 90. South Africa Gastroesophageal Reflux Drugs Value Growth 2015-2020 ($ Millions)
Figure 91. Israel Gastroesophageal Reflux Drugs Consumption Growth 2015-2020 (K Units)
Figure 92. Israel Gastroesophageal Reflux Drugs Value Growth 2015-2020 ($ Millions)
Figure 93. Turkey Gastroesophageal Reflux Drugs Consumption Growth 2015-2020 (K Units)
Figure 94. Turkey Gastroesophageal Reflux Drugs Value Growth 2015-2020 ($ Millions)
Figure 95. GCC Countries Gastroesophageal Reflux Drugs Consumption Growth 2015-2020 (K Units)
Figure 96. GCC Countries Gastroesophageal Reflux Drugs Value Growth 2015-2020 ($ Millions)
Figure 97. Global Gastroesophageal Reflux Drugs Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 98. Global Gastroesophageal Reflux Drugs Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 99. Americas Gastroesophageal Reflux Drugs Consumption 2021-2025 (K Units)
Figure 100. Americas Gastroesophageal Reflux Drugs Value 2021-2025 ($ Millions)
Figure 101. APAC Gastroesophageal Reflux Drugs Consumption 2021-2025 (K Units)
Figure 102. APAC Gastroesophageal Reflux Drugs Value 2021-2025 ($ Millions)
Figure 103. Europe Gastroesophageal Reflux Drugs Consumption 2021-2025 (K Units)
Figure 104. Europe Gastroesophageal Reflux Drugs Value 2021-2025 ($ Millions)
Figure 105. Middle East & Africa Gastroesophageal Reflux Drugs Consumption 2021-2025 (K Units)
Figure 106. Middle East & Africa Gastroesophageal Reflux Drugs Value 2021-2025 ($ Millions)
Figure 107. United States Gastroesophageal Reflux Drugs Consumption 2021-2025 (K Units)
Figure 108. United States Gastroesophageal Reflux Drugs Value 2021-2025 ($ Millions)
Figure 109. Canada Gastroesophageal Reflux Drugs Consumption 2021-2025 (K Units)
Figure 110. Canada Gastroesophageal Reflux Drugs Value 2021-2025 ($ Millions)
Figure 111. Mexico Gastroesophageal Reflux Drugs Consumption 2021-2025 (K Units)
Figure 112. Mexico Gastroesophageal Reflux Drugs Value 2021-2025 ($ Millions)
Figure 113. Brazil Gastroesophageal Reflux Drugs Consumption 2021-2025 (K Units)
Figure 114. Brazil Gastroesophageal Reflux Drugs Value 2021-2025 ($ Millions)
Figure 115. China Gastroesophageal Reflux Drugs Consumption 2021-2025 (K Units)
Figure 116. China Gastroesophageal Reflux Drugs Value 2021-2025 ($ Millions)
Figure 117. Japan Gastroesophageal Reflux Drugs Consumption 2021-2025 (K Units)
Figure 118. Japan Gastroesophageal Reflux Drugs Value 2021-2025 ($ Millions)
Figure 119. Korea Gastroesophageal Reflux Drugs Consumption 2021-2025 (K Units)
Figure 120. Korea Gastroesophageal Reflux Drugs Value 2021-2025 ($ Millions)
Figure 121. Southeast Asia Gastroesophageal Reflux Drugs Consumption 2021-2025 (K Units)
Figure 122. Southeast Asia Gastroesophageal Reflux Drugs Value 2021-2025 ($ Millions)
Figure 123. India Gastroesophageal Reflux Drugs Consumption 2021-2025 (K Units)
Figure 124. India Gastroesophageal Reflux Drugs Value 2021-2025 ($ Millions)
Figure 125. Australia Gastroesophageal Reflux Drugs Consumption 2021-2025 (K Units)
Figure 126. Australia Gastroesophageal Reflux Drugs Value 2021-2025 ($ Millions)
Figure 127. Germany Gastroesophageal Reflux Drugs Consumption 2021-2025 (K Units)
Figure 128. Germany Gastroesophageal Reflux Drugs Value 2021-2025 ($ Millions)
Figure 129. France Gastroesophageal Reflux Drugs Consumption 2021-2025 (K Units)
Figure 130. France Gastroesophageal Reflux Drugs Value 2021-2025 ($ Millions)
Figure 131. UK Gastroesophageal Reflux Drugs Consumption 2021-2025 (K Units)
Figure 132. UK Gastroesophageal Reflux Drugs Value 2021-2025 ($ Millions)
Figure 133. Italy Gastroesophageal Reflux Drugs Consumption 2021-2025 (K Units)
Figure 134. Italy Gastroesophageal Reflux Drugs Value 2021-2025 ($ Millions)
Figure 135. Russia Gastroesophageal Reflux Drugs Consumption 2021-2025 (K Units)
Figure 136. Russia Gastroesophageal Reflux Drugs Value 2021-2025 ($ Millions)
Figure 137. Spain Gastroesophageal Reflux Drugs Consumption 2021-2025 (K Units)
Figure 138. Spain Gastroesophageal Reflux Drugs Value 2021-2025 ($ Millions)
Figure 139. Egypt Gastroesophageal Reflux Drugs Consumption 2021-2025 (K Units)
Figure 140. Egypt Gastroesophageal Reflux Drugs Value 2021-2025 ($ Millions)
Figure 141. South Africa Gastroesophageal Reflux Drugs Consumption 2021-2025 (K Units)
Figure 142. South Africa Gastroesophageal Reflux Drugs Value 2021-2025 ($ Millions)
Figure 143. Israel Gastroesophageal Reflux Drugs Consumption 2021-2025 (K Units)
Figure 144. Israel Gastroesophageal Reflux Drugs Value 2021-2025 ($ Millions)
Figure 145. Turkey Gastroesophageal Reflux Drugs Consumption 2021-2025 (K Units)
Figure 146. Turkey Gastroesophageal Reflux Drugs Value 2021-2025 ($ Millions)
Figure 147. GCC Countries Gastroesophageal Reflux Drugs Consumption 2021-2025 (K Units)
Figure 148. GCC Countries Gastroesophageal Reflux Drugs Value 2021-2025 ($ Millions)
Figure 149. Bayer Gastroesophageal Reflux Drugs Market Share (2018-2020)
Figure 150. Luoxin Gastroesophageal Reflux Drugs Market Share (2018-2020)
Figure 151. Cadila Pharmaceuticals Gastroesophageal Reflux Drugs Market Share (2018-2020)
Figure 152. Jiangsu Aosaikang Gastroesophageal Reflux Drugs Market Share (2018-2020)
Figure 153. Eisai Gastroesophageal Reflux Drugs Market Share (2018-2020)
Figure 154. AstraZeneca Gastroesophageal Reflux Drugs Market Share (2018-2020)
Figure 155. Takeda Gastroesophageal Reflux Drugs Market Share (2018-2020)
Figure 156. Pfizer Gastroesophageal Reflux Drugs Market Share (2018-2020)
Figure 157. NCPC Gastroesophageal Reflux Drugs Market Share (2018-2020)
Figure 158. Altana Pharma Gastroesophageal Reflux Drugs Market Share (2018-2020)
